Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ

por Tamura, Nobuko, Tsuda, Hitoshi, Yoshida, Masayuki, Hojo, Takashi, Akashi-Tanaka, Sadako, Kinoshita, Takayuki, Sugihara, Kenichi
Publicado 2015

Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer

por Shingaki, Sumito, Kogawa, Takahiro, Shimokawa, Mototsugu, Harano, Kenichi, Naito, Yoichi, Kusuhara, Shota, Fujimoto, Yumi, Matsubara, Nobuaki, Hosono, Ako, Mukai, Hirofumi, Onishi, Tatsuya, Hojo, Takashi, Mukohara, Toru
Publicado 2020

Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast

por Hiratsuka, Miyuki, Hasebe, Takahiro, Ichinose, Yuki, Sakakibara, Ayaka, Fujimoto, Akihiro, Wakui, Noriko, Shibasaki, Satomi, Hirasaki, Masataka, Yasuda, Masanori, Nukui, Akemi, Shimada, Hiroko, Yokogawa, Hideki, Matsuura, Kazuo, Hojo, Takashi, Osaki, Akihiko, Saeki, Toshiaki
Publicado 2022

Establishment of a deep‐learning system to diagnose BI‐RADS4a or higher using breast ultrasound for clinical application

por Hayashida, Tetsu, Odani, Erina, Kikuchi, Masayuki, Nagayama, Aiko, Seki, Tomoko, Takahashi, Maiko, Futatsugi, Noriyuki, Matsumoto, Akiko, Murata, Takeshi, Watanuki, Rurina, Yokoe, Takamichi, Nakashoji, Ayako, Maeda, Hinako, Onishi, Tatsuya, Asaga, Sota, Hojo, Takashi, Jinno, Hiromitsu, Sotome, Keiichi, Matsui, Akira, Suto, Akihiko, Imoto, Shigeru, Kitagawa, Yuko
Publicado 2022